)
United States approves new drug to treat Alzheimer's disease
United States regulators approved Biogen Inc's aducanumab as the first treatment to attack a likely cause of Alzheimer's disease. Watch the report to know more.
United States regulators approved Biogen Inc's aducanumab as the first treatment to attack a likely cause of Alzheimer's disease. Watch the report to know more.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)